Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)) and Olaratumab
Determining the interaction of Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)) and Olaratumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Olaratumab Intravenous
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Oleptro
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Oleptro Oral
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Olmesartan
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Olmesartan and Hydrochlorothiazide
- Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))-Olmesartan Medoxomil
- Olaratumab-Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
- Olaratumab-Nuwiq recombinant
- Olaratumab-NuZole
- Olaratumab-Nuzyra
- Olaratumab-Nuzyra (Omadacycline Injection)
- Olaratumab-Nuzyra (Omadacycline Tablets)